Annual Retained Earnings
$2.52 B
+$552.89 M+28.14%
December 31, 2023
Summary
- As of February 11, 2025, RPRX annual retained earnings is $2.52 billion, with the most recent change of +$552.89 million (+28.14%) on December 31, 2023.
- During the last 3 years, RPRX annual retained earnings has risen by +$596.95 million (+31.08%).
- RPRX annual retained earnings is now -10.89% below its all-time high of $2.83 billion, reached on December 31, 2019.
Performance
RPRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$2.76 B
+$386.43 M+16.25%
September 30, 2024
Summary
- As of February 11, 2025, RPRX quarterly retained earnings is $2.76 billion, with the most recent change of +$386.43 million (+16.25%) on September 30, 2024.
- Over the past year, RPRX quarterly retained earnings has increased by +$337.24 million (+13.89%).
- RPRX quarterly retained earnings is now -2.14% below its all-time high of $2.83 billion, reached on December 31, 2019.
Performance
RPRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RPRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.1% | +13.9% |
| 3 y3 years | +31.1% | +13.9% |
| 5 y5 years | +107.0% | - |
RPRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.1% | at high | +40.7% |
| 5 y | 5-year | -10.9% | +31.1% | -2.1% | +75.9% |
| alltime | all time | -10.9% | +107.0% | -2.1% | +75.9% |
Royalty Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.76 B(+16.2%) |
| Jun 2024 | - | $2.38 B(-2.0%) |
| Mar 2024 | - | $2.43 B(-3.6%) |
| Dec 2023 | $2.52 B(+28.1%) | $2.52 B(+17.9%) |
| Sep 2023 | - | $2.13 B(-5.2%) |
| Jun 2023 | - | $2.25 B(+1.6%) |
| Mar 2023 | - | $2.22 B(+12.8%) |
| Dec 2022 | $1.96 B | $1.96 B(-21.6%) |
| Sep 2022 | - | $2.50 B(+2.4%) |
| Jun 2022 | - | $2.45 B(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.22 B(-1.4%) |
| Dec 2021 | $2.26 B(+17.4%) | $2.26 B(-2.8%) |
| Sep 2021 | - | $2.32 B(+1.3%) |
| Jun 2021 | - | $2.29 B(+19.1%) |
| Mar 2021 | - | $1.92 B(+0.2%) |
| Dec 2020 | $1.92 B(-32.0%) | $1.92 B(+6.3%) |
| Sep 2020 | - | $1.81 B(+15.0%) |
| Jun 2020 | - | $1.57 B(-38.7%) |
| Mar 2020 | - | $2.56 B(-9.3%) |
| Dec 2019 | $2.83 B(+132.3%) | $2.83 B |
| Dec 2018 | $1.22 B | - |
FAQ
- What is Royalty Pharma annual retained earnings?
- What is the all time high annual retained earnings for Royalty Pharma?
- What is Royalty Pharma annual retained earnings year-on-year change?
- What is Royalty Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Royalty Pharma?
- What is Royalty Pharma quarterly retained earnings year-on-year change?
What is Royalty Pharma annual retained earnings?
The current annual retained earnings of RPRX is $2.52 B
What is the all time high annual retained earnings for Royalty Pharma?
Royalty Pharma all-time high annual retained earnings is $2.83 B
What is Royalty Pharma annual retained earnings year-on-year change?
Over the past year, RPRX annual retained earnings has changed by +$552.89 M (+28.14%)
What is Royalty Pharma quarterly retained earnings?
The current quarterly retained earnings of RPRX is $2.76 B
What is the all time high quarterly retained earnings for Royalty Pharma?
Royalty Pharma all-time high quarterly retained earnings is $2.83 B
What is Royalty Pharma quarterly retained earnings year-on-year change?
Over the past year, RPRX quarterly retained earnings has changed by +$337.24 M (+13.89%)